首页> 外国专利> 3-METHOXY-4-1-METHYL-5-(2-METHYL-4,4,4- TRIFLUOROBUTYLCARBAMOYL) INDOLE-3-YL- -METHYL-N-(-METHYLPHENYLSULFONYL) BENZAMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AS LEUKOTRIENE ANTAGONISTS, AND PRODUCTS FOR SYNTHESIS OF THEIRS

3-METHOXY-4-1-METHYL-5-(2-METHYL-4,4,4- TRIFLUOROBUTYLCARBAMOYL) INDOLE-3-YL- -METHYL-N-(-METHYLPHENYLSULFONYL) BENZAMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AS LEUKOTRIENE ANTAGONISTS, AND PRODUCTS FOR SYNTHESIS OF THEIRS

机译:3-甲氧基-4- [1-甲基-5-(2-甲基-4,4,4-三氟叔丁基氨基甲酰基)吲哚-3-基-甲基] -N-(-甲基苯磺酰基)苯甲酰胺或其药学上可接受的盐,为白三烯拮抗剂和用于合成它们的产品

摘要

The present invention concerns novel carbamoyl derivatives of formula I, set out herein, which antagonize the pharmacological actions of one or more of the arachidonic acid metabolites known as leukotrienes, making them useful whenever such antagonism is desired, such as in the treatment of those diseases in which leukotrienes are implicated, for example, in the treatment of allergic or inflammatory diseases, or of endotoxic or traumatic shock conditions. The invention also provides pharmaceutical compositions containing the novel derivatives for use in such treatments, methods for their use and processes and intermediates for the manufacture of the novel derivatives.
机译:本发明涉及本文所述的式I的新型氨基甲酰基衍生物,其拮抗一种或多种称为白三烯的花生四烯酸代谢物的药理作用,使得它们在需要这种拮抗作用时(例如在治疗那些疾病中)有用。其中白三烯参与例如变应性或炎性疾病或内毒素或外伤性休克病的治疗。本发明还提供了用于这种治疗的包含新型衍生物的药物组合物,其使用方法以及用于制造新型衍生物的方法和中间体。

著录项

  • 公开/公告号RU2002740C1

    专利类型

  • 公开/公告日1993-11-15

    原文格式PDF

  • 申请/专利权人 IMPERIAL KEMIKAL INDASTRIZ PLS (GV);

    申请/专利号SU19904831920

  • 发明设计人 ROBERT TOMZ DZHAKOBZ;

    申请日1990-12-10

  • 分类号C07D209/12;C07D209/14;C07D209/24;C07C233/11;C07C211/06;A61K31/405;

  • 国家 RU

  • 入库时间 2022-08-22 04:37:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号